In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model
The FASEB Journal · 2023
DOI: 10.1096/fj.202202036r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Shunichi Watanabe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Pathobiology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Japan. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, CD40 Ligand. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Science Society, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The tumor microenvironment (TME) strongly affects the clinical outcomes of immunotherapy. This study aimed to activate the antitumor immune response by manipulating the TME by transfecting genes encoding relevant cytokines into tumor cells using a synthetic vehicle, which is designed to target tumor cells and promote the expression of transfected genes. Lung tumors were formed by injecting CT26.WT intravenously into BALB/c mice. Upon intravenous injection of the green fluorescent protein‐coding plasmid encapsulated in the vehicle, 14.2% tumor‐specific expression was observed. Transfection of the granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and CD40 ligand (L)‐plasmid combination and interferon gamma (IFNγ) and CD40L‐plasmid combination showed 45.5% and 54.5% complete remission (CR), respectively, on day 60; alternate treatments with both the plasmid combinations elicited 66.7% CR, while the control animals died within 48 days. Immune status analysis revealed that the density of dendritic cells significantly increased in tumors, particularly after GM‐CSF‐ and CD40L‐gene transfection, while that of regulatory T cells significantly decreased. The proportion of activated killer cells and antitumoral macrophages significantly increased, specifically after IFNγ and CD40L transfection. Furthermore, the level of the immune escape molecule programmed death ligand‐1 decreased in tumors after transfecting these cytokine genes. As a result, tumor cell‐specific transfection of these cytokine genes by the synthetic vehicle significantly promotes antitumor immune responses in the TME, a key aim for visceral tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Pathobiology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Japan.
- Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Japan.
- Department of Applied Chemistry, Graduate School of Engineering, Osaka Metropolitan University, Sakai, Japan.
- Bioscience Research Laboratory, Sumitomo Chemical Company, Ltd., Osaka, Japan.
- Department of Integrated Structural Biosciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Japan.
- Department of Integrated Structural Biosciences, Graduate School of Veterinary Science, Osaka Metropolitan University, Izumisano, Japan.
ORCID-Profile: Shunichi Watanabe, Ayaka Takagi, Eiji Yuba, Chie Kojima, Akikazu Matsumoto, Jun Tanikawa, Tetsuya Kawamura, Takeshi Izawa, Takashi Akazawa, Ryoji Kanegi, Shingo Hatoya, Toshio Inaba, Kikuya Sugiura
Förderung
- Japan Agency for Medical Research and Development
- Japan Science Society
- Japan Society for the Promotion of Science
Zitieren
APA
Watanabe, S., Takagi, A., Yuba, E., Kojima, C., Dei, N., Matsumoto, A., Tanikawa, J., Kawamura, T., De Silva, N. H., Izawa, T., Akazawa, T., Kanegi, R., Hatoya, S., Inaba, T., & Sugiura, K. (2023). In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model. The FASEB Journal. https://doi.org/10.1096/fj.202202036r
Vancouver
Watanabe S, Takagi A, Yuba E, Kojima C, Dei N, Matsumoto A, et al. In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model. The FASEB Journal. 2023. doi:10.1096/fj.202202036r
BibTeX
@article{Watanabe2023,
author = {Watanabe, Shunichi and Takagi, Ayaka and Yuba, Eiji and Kojima, Chie and Dei, Nanako and Matsumoto, Akikazu and Tanikawa, Jun and Kawamura, Tetsuya and De Silva, Nadeeka H and Izawa, Takeshi and Akazawa, Takashi and Kanegi, Ryoji and Hatoya, Shingo and Inaba, Toshio and Sugiura, Kikuya},
title = {In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202202036r}
}
EUVIMED